Monitor future insider transactions and upcoming earnings filings for signs of financial performance trends; this grant is a retention measure for interim leadership and does not signal immediate operational changes.
Price Chart
Executive Summary
Xenetic Biosciences granted 100,000 restricted shares to its Interim CEO and CFO, James Parslow, with 7,000 shares vesting immediately and the remainder vesting annually over three years. The filing is a routine compensatory arrangement disclosure.
Key Facts
- James Parslow, Interim CEO and CFO, granted 100,000 restricted shares
- 7,000 shares vest immediately; 31,000 shares vest annually on each of the next three anniversaries
- Full vesting upon a Change in Control
- Filing relates to compensatory arrangements under Item 5.02
Financial Impact
Dilutive impact of 100,000 shares, representing approximately 0.4% of XBIO's current market cap based on $7M valuation
Risk Factors
- Potential share dilution from equity compensation
- Leadership instability due to interim executive role
- Low market cap increases volatility risk from insider ownership changes
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001683168-26-003203 |
| Document: xenetic_8k.htm | 0001683168-26-003203 |
| Document: 0001683168-26-003203-index-headers.html | 0001683168-26-003203 |
| Document: 0001683168-26-003203-index.html | 0001683168-26-003203 |
| Document: 0001683168-26-003203.txt | 0001683168-26-003203 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 8-K | $2.47 $1.93 | ▼ −21.86% | ▼ −21.44% | $1.84 (−25.51%) |
Sep 18, 2026 5w ago | SC 13G | $2.77 $1.99 | ▼ −28.16% | ▼ −28.36% | $1.84 (−33.57%) |
Sep 16, 2026 5w ago | 8-K | $2.19 $2.10 | ▼ −4.11% | ▼ −7.29% | $1.84 (−15.98%) |
Aug 7, 2026 11w ago | 8-K | $3.17 $4.67 | ▲ +47.32% | ▲ +47.72% | $1.84 (−41.96%) |
May 13, 2026 23w ago | 8-K | $3.18 $3.00 | ▼ −5.66% | ▼ −5.05% | $1.84 (−42.14%) |
Apr 24, 2026 26w ago | 10-K/A | $3.03 $3.07 | ▲ +1.18% | ▼ −3.77% | $1.84 (−39.27%) |
Apr 24, 2026 26w ago | 8-K | $3.03 $3.07 | ▲ +1.18% | ▼ −3.77% | $1.84 (−39.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers